Novel regimens of bedaquiline-pyrazinamide combined with moxifloxacin, rifabutin, delamanid and/or OPC-167832 in murine tuberculosis models
E. Nuermberger, R. Tasneen, A. Garcia, P. J. Converse, M. D. Zimmerman, V. A. Dartois, E. V. Kurbatova, A. Vernon, W. Carr, J. E. Stout, K. E. Dooley
This paper tests novel tuberculosis treatment regimens in mice, finding that BZM-based regimens show improved sterilizing activity compared to standard care.
bioRxiv · Dec 21, 2021Microbiology